Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001346302-21-000026
Filing Date
2021-03-09
Accepted
2021-03-09 16:39:33
Documents
89
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xers-20201231.htm   iXBRL 10-K 2158259
2 EX-10.34 a202010-kexhibit1034.htm EX-10.34 56898
3 EX-10.36 a202010-kexhibit1036.htm EX-10.36 699078
4 EX-23.1 a202010-kexhibit231.htm EX-23.1 3190
5 EX-31.1 a202010-kexhibit311.htm EX-31.1 10007
6 EX-31.2 a202010-kexhibit312.htm EX-31.2 9937
7 EX-32.1 a202010-kexhibit321.htm EX-32.1 5547
8 EX-32.2 a202010-kexhibit322.htm EX-32.2 5372
14 image_01a.jpg GRAPHIC 646638
15 xers-20201231_g1.jpg GRAPHIC 75672
16 xers-20201231_g2.jpg GRAPHIC 43830
17 xers-20201231_g3.jpg GRAPHIC 53059
18 xers-20201231_g4.jpg GRAPHIC 55375
19 xers-20201231_g5.jpg GRAPHIC 28958
20 xers-20201231_g6.jpg GRAPHIC 31023
21 xers-20201231_g7.jpg GRAPHIC 30428
  Complete submission text file 0001346302-21-000026.txt   10754094

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20201231.xsd EX-101.SCH 56281
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20201231_cal.xml EX-101.CAL 42688
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20201231_def.xml EX-101.DEF 313946
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20201231_lab.xml EX-101.LAB 689656
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20201231_pre.xml EX-101.PRE 460554
22 EXTRACTED XBRL INSTANCE DOCUMENT xers-20201231_htm.xml XML 1163207
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

EIN.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38536 | Film No.: 21726444
SIC: 2834 Pharmaceutical Preparations